Ces radiol. 2022, 76(4):237-242 | DOI: 10.55095/CesRadiol2022/027

The role of MRI in the diagnosis of neuromyelitis optica spectrum disorder - NMOSDCase report

Monika Daňová1,2, Anna Cvengrošová3, Marek Chmelík2
1 ProMagnet s.r.o., Magnetická rezonancia Prešov, FNsP J. A. Reimana Prešov
2 Prešovská univerzita v Prešove, Fakulta zdravotníckych odborov, Katedra medicínsko-technických odborov
3 Neurologické oddelenie FNsP J. A. Reimana Prešov

Neuromyelitis optica (NMO) and neuromyelitis optica spectrum disorders (NMOSD)have been clearly separated from sclerosis multiplex (SM) as a distinctnosological entity based on clinical and paraclinical criteria, particularlyMRI and the presence of antibodies to aquaporin-4 (AQP4). The capabilities ofMRI, together with serological testing for antibodies to AQP4 and myelinoligodendrocyte glycoprotein (MOG), play an important role in the diagnosisand differential diagnosis of NMOSD from SM and MOGAD-myelin oligodendrocyteglycoprotein associated disease.

Keywords: magnetic resonance imaging spectrum neuromyelitis optica disorders,aquaporin-4 (AQP4), myelin oligodendrocyte glycoprotein (MOG)

Published: December 1, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Daňová M, Cvengrošová A, Chmelík M. The role of MRI in the diagnosis of neuromyelitis optica spectrum disorder - NMOSD. Ces radiol. 2022;76(4):237-242. doi: 10.55095/CesRadiol2022/027.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Szilasiová J, Gazda J, Cimprichová A, et al. Incidence and prevalence of neuromyelitis optica spectrum disorders in Slovakia, Neurological Research; 44(1): 38-34. doi: 10.1080/01616412.2021.1952741
    2. Szilasiová J. Spektrum ochorení neuromyelitis optica Neurol. Praxi 2019; 20(5): 368-372. doi: 10.36290/neu.2019.059 Go to original source...
    3. Solomon JM, Paul F, Chien C, Oh J, Rotstein DL. A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course. Ther Adv Neurol Disord 2021; 14: 17562864211014389. doi: 10.1177/17562864211014389. PMID: 34035837; PMCID: PMC8111516. Go to original source... Go to PubMed...
    4. Libertínová L. Epidemiologie, klinický obraz a průběh onemocnění u neuromyelitis optica a onemocnění jejího širšího spektra. Cesk Slov Neurol N 2020; 83/116(Suppl 1): 15-19 doi: 10.14735/amcsnn2020S15 Go to original source...
    5. Kuchling J, Paul F. Visualizing the Central Nervous System: Imaging Tools for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders. Front Neurol 2020; 11: 450. doi: 10.3389/fneur.2020.00450. PMID: 32625158; PMCID: PMC7311777 Go to original source... Go to PubMed...
    6. Dutra BG, José da Rocha A, Nunes RH, et al. Neuromyelitis Optica Spectrum Disorders: Spectrum of MR Imaging Findings and Their Differential Diagnosis- -Erratum. Radiographics 2018; 38(2): 662. doi: 10.1148/rg.2018184002. Erratum for: Radiographics 2018; 38(1): 169-193. PMID: 29528835. Go to original source... Go to PubMed...
    7. Vaněčková M. Nálezy na magnetické rezonanci u neuromyelitis optica a onemocnění jejího širšího spektra. Cesk Slov Neurol N 2020; 83/116(Suppl 1): 20-30. doi: 10.14735/amcsnn2020S20 Go to original source...
    8. Mazúrová T, Kantorová E, Kurča E, et al. Optická neuritída pri sclerosis multiplex a neuromyelitis optica/neuromyelitis optica spektrum ochorení. Neurológia 2019; 14(2): 62-69.
    9. Wingerchuk DM, Banwell B, Bennett JL, et al. International Panel for NMO Diagnosis. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015; 85(2): 177-189. Go to original source... Go to PubMed...
    10. Kantorová E, Marcinek J, Zeleňák K, et al. Tumefactive demyelination of the spinal cord: A case report. Spinal Cord 2015; 53: 877-880. Go to original source... Go to PubMed...
    11. Nytrová P, Horáková D. Neuromyelitis optica. Cesk Slov Neurol N 2015; 78/111(2): 130-137. Go to original source...
    12. Jarius S, Paul F, Aktas O, et al. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflamm 2018; 15(1): 134. Go to original source... Go to PubMed...
    13. Wattjes MP, Ciccarelli O, Reich DS, et al. Magnetic Resonance Imaging in Multiple Sclerosis study group; Consortium of Multiple Sclerosis Centres; North American Imaging in Multiple Sclerosis Cooperative MRI guidelines working group. 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. Lancet Neurol 2021; 20(8): 653-670. doi: 10.1016/S1474-4422(21)00095-8 [Epub 2021 Jun 14]. PMID: 34139157. Go to original source... Go to PubMed...
    14. Gdovinová Z, a kol. Vybrané kapitoly zo špeciálnej neurológie. Košice: ŠafarikPress 2021.

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content